These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 33576708)

  • 21. The Impact of the COVID-19 Pandemic on the Uptake of Influenza Vaccine: UK-Wide Observational Study.
    Bachtiger P; Adamson A; Chow JJ; Sisodia R; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Apr; 7(4):e26734. PubMed ID: 33651708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: A global qualitative analysis.
    Volkmann AM; Goldin S; McMurren B; Gapare C; Anne Pratt B; Frost L; Desai S
    Vaccine; 2024 Oct; 42 Suppl 4():125534. PubMed ID: 38531724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Ghiga I; Richardson S; Álvarez AMR; Kato M; Naidoo D; Otsu S; Nguyen PT; Nguyen PN; Nguyen T
    Vaccine; 2021 Jan; 39(2):364-371. PubMed ID: 33293160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
    Zhang T; Bai XF; Wang W; Liu XX; Zhang XX; Wang DY; Zhang SB; Chen ZP; He HQ; Huang ZY; Xu AQ; Peng ZB; Feng LZ; Yu WZ; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):103-107. PubMed ID: 34954956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
    Johnson RA; White RC; Disbrow GL
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129930. PubMed ID: 36302122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
    Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
    Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
    Ramezanpour B; Pronker ES; Kreijtz JH; Osterhaus AD; Claassen E
    Vaccine; 2015 Aug; 33(35):4349-58. PubMed ID: 26048779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against seasonal influenza and socio-economic and environmental factors as determinants of the geographic variation of COVID-19 incidence and mortality in the Italian elderly.
    Cocco P; Meloni F; Coratza A; Schirru D; Campagna M; De Matteis S
    Prev Med; 2021 Feb; 143():106351. PubMed ID: 33275965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic.
    Li K; Yu T; Seabury SA; Dor A
    Vaccine; 2022 Apr; 40(19):2696-2704. PubMed ID: 35370018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience.
    Rockman S; Taylor B; McCauley JW; Barr IG; Longstaff R; Bahra R
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.